Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer

IntroductionOvarian cancer recurs in most High Grade Serous Ovarian Cancer (HGSOC) patients, including initial responders, after standard of care. To improve patient survival, we need to identify and understand the factors contributing to early or late recurrence and therapeutically target these mec...

詳細記述

書誌詳細

主要な著者:	Nicholas Adzibolosu, Ayesha B. Alvero, Rouba Ali-Fehmi, Radhika Gogoi, Logan Corey, Roslyn Tedja, Hussein Chehade, Vir Gogoi, Robert Morris, Matthew Anderson, Julie Vitko, Clarissa Lam, Douglas B. Craig, Sorin Draghici, Thomas Rutherford, Gil Mor
フォーマット:	Artigo
言語:	Inglês
出版事項:	Frontiers Media S.A. 2023-06-01
シリーズ:	Frontiers in Immunology
主題:	ovarian cancer chemoresistance cold tumors hot tumors immune response
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1204148/full
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!